-
×
Gulfcoast: Ultrasound-Guided Peripheral Nerve Injections in an MSK Practice
1 ×15.00 $12.75 $ -
×
Masters of Pathology : Pancreatic Pathology 2019
2 ×35.00 $29.75 $ -
×
Ventricular Systolic Function, 2nd edition (Original PDF from Publisher)
1 ×9.00 $7.65 $ -
×
2020 Classic Lectures in Gastrointestinal Imaging
1 ×40.00 $34.00 $
Scripps 40th New Treatments in Chronic Liver Disease 2026
20.00 $
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course
Samples for Courses Can be found here : Free Samples Here!
Description
+ Include: 14 videos Only no PDFs
+ Target Audience: hepatologists, gastroenterologists, internists, transplant specialists
Overview
New Treatments in Chronic Liver Disease will highlight the latest advancements in medications and therapies for liver care and transplantation. The program will offer an in-depth review of clinical trials and real-world data on oral treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. This annual CME conference delivers a comprehensive yet targeted program designed to provide physicians with the latest updates and practical insights for managing liver diseases.
Objectives
Upon completion of this activity, participants should be able to:
- Cite new strategies for identifying and managing metabolic liver disease.
- Review updated goals and guidelines for curing Delta Hepatitis, HBV and HCV.
- Discuss potential new treatments for alcohol-related liver disease.
- Summarize novel markers and therapies in PBC and PSC.
- Evaluate liver masses and new therapeutic options for HCC.
- Employ strategies for treating and managing ascites and hepatorenal syndrome.
| Topic | Duration |
|---|---|
| New Treatments in Chronic Liver Disease 2026 | 33:58 |
| The Emerging Clinical Entity of MetALD: Diagnosis, Risk, and Management | 30:05 |
| MASH Cirrhosis: Is It Reversible? | 41:05 |
| Obesity Treatment: The Essentials (2026) | 48:53 |
| Panel Discussion: MASLD, ALD, and Clinical Practice Q&A | 28:38 |
| Diagnosis and Management of Autoimmune Hepatitis | 31:38 |
| Drug Induced Liver Injury (2026) | 24:43 |
| Hepatitis B Cure: Is It Possible? Is It Worth It? | 23:47 |
| Using Medication Assisted Therapy in Hepatitis C | 18:03 |
| Delta Hepatitis | 21:29 |
| Panel Discussion: Autoimmune Hepatitis (AIH), Checkpoint Inhibitor-Induced Liver Injury, and the Management of Hepatitis B and C | 71:49 |
| Liver Transplant Selection Board (2026) | 46:36 |
| Updates in PBC and PSC | 13:39 |
| Panel Discussion: Liver Disease Management, Surveillance, and Transplantation | — |
Related products
